Rifaximin
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Rifaximin is used to treat diarrhea and irritable bowel syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 25, 2004, and the first generic was approved Mar 19, 2026. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $1.2 billion on Rifaximin across 417,000 claims for 105,000 beneficiaries.
Rifaximin is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $10.72 to $55.28 per EA — the most expensive product costs about 5.2× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$10.72 – $55.28
per EA
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing RIFAXIMIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
XIFAXAN 550 MG TABLET | $55.2802 per EA | — |
XIFAXAN 550 MG TABLET | $55.2802 per EA | — |
XIFAXAN 200 MG TABLET | $10.7162 per EA | — |
Frequently Asked Questions
What is Rifaximin used to treat?
Rifaximin is used to treat diarrhea and irritable bowel syndrome, per the National Library of Medicine's MED-RT classification.
When did Rifaximin become available as a generic?
FDA approved the first generic Rifaximin (ANDA) on Mar 19, 2026. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Rifaximin?
In 2024, Medicare Part D spent $1.2 billion on Rifaximin across 417,000 claims for 105,000 beneficiaries.
How many Rifaximin products are on the market?
The Rifaximin drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Rifaximin?
NADAC reference prices for Rifaximin range from $10.7162 to $55.2802 per EA — the most expensive product costs about 5.2× the cheapest.
Which manufacturers make Rifaximin?
1 manufacturer lists Rifaximin in NADAC. Ranked by number of NDCs, the largest are Salix Pharmaceuticals Inc. (3).